Post

Next Gen 2 by Bioprojet SCR for Narcolepsy: Likelihood of Approval

Next Gen 2 is under clinical development by Bioprojet SCR and currently in Phase I for Narcolepsy. According to GlobalData, …

RO-7269162 by F. Hoffmann-La Roche for Alzheimer’s Disease: Likelihood of Approval

RO-7269162 is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Alzheimer's Disease. According to GlobalData, …

(Atezolizumab + tiragolumab) by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval

(Atezolizumab + tiragolumab) is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Solid Tumor. According …

CRTE-7A2 by Beijing Corregene Biotechnology for Anal Cancer: Likelihood of Approval

CRTE-7A2 is under clinical development by Beijing Corregene Biotechnology and currently in Phase I for Anal Cancer. According to GlobalData, …

CRTE-7A2 by Beijing Corregene Biotechnology for Head And Neck Cancer: Likelihood of Approval

CRTE-7A2 is under clinical development by Beijing Corregene Biotechnology and currently in Phase I for Head And Neck Cancer. According …